AJP - Regu Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 275: R1146-R1151, 1998;
0363-6119/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Del Rey, A.
Right arrow Articles by Besedovsky, H. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Del Rey, A.
Right arrow Articles by Besedovsky, H. O.
Vol. 275, Issue 4, R1146-R1151, October 1998

Cytokines mediate protective stimulation of glucocorticoid output during autoimmunity: involvement of IL-1

Adriana Del Rey1, Isabel Klusman2, and Hugo O. Besedovsky1

1 Division of Immunophysiology, Institute of Physiology, Medical Faculty, D-35037 Marburg, Germany; and 2 Division of Neurobiology, Department of Research, Kantonsspital, CH-4031 Basel, Switzerland

Endogenous glucocorticoid levels are increased during experimental autoimmune encephalomyelitis (EAE) in Lewis rats. Although this endocrine response is essential for survival, the mechanism that triggers the stimulation of glucocorticoid output during the disease remains unknown. We report here that 1) after immunization with the encephalitogenic antigen myelin basic protein (MBP), increased blood glucocorticoid levels are not only observed in Lewis rats, but also in PVG rats, which do not develop EAE; 2) immune cells obtained from animals with EAE and stimulated in vitro with MBP produced mediators that increased glucocorticoid levels when administered to naive recipients; and 3) acute in vivo blockade of interleukin-1 (IL-1) receptors inhibited, to a large extent, the increase in corticosterone levels during EAE. These results show that the increase in corticosterone levels after immunization with MBP can be dissociated from the stress of the paralytic attack that characterizes EAE. Furthermore, they indicate that an endocrine response, which is decisive for the prevention or moderation of EAE, is mainly the result of the stimulation of the hypothalamic-pituitary-adrenal axis by cytokines produced during the immune response that induces the autoimmune disease.

corticosterone; neuroimmunology; interleukin-1 receptor antagonist; experimental autoimmune encephalomyelitis


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. S. Exton, M. Schult, S. Donath, T. Strubel, U. Bode, A. del Rey, J. Westermann, and M. Schedlowski
Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1710 - R1717.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online